The influence of P2Y12 antagonists on vascular NO signalling

0044 English OPEN
Sagan, Ewelina Nina;
  • Subject: R1 | RM

P2Y12 antagonists are pharmacological agents used clinically in advanced stages of coronary artery disease in order to inhibit ADP-induced activation and aggregation of platelets and prevent deadly thrombotic events. Of the orally-prescribed P2Y12 antagonists available ... View more
Share - Bookmark